Sterling Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$541K Buy
588
+1
+0.2% +$1.01K 0.15% 56
2025
Q4
$631K Sell
587
-794
-57% -$759K 0.18% 52
2025
Q3
$1.05M Sell
1,381
-41
-3% -$30.5K 0.32% 42
2025
Q2
$1.11M Buy
+1,422
New +$1.1M 0.38% 40
2024
Q4
$1.15M Hold
1,494
0.43% 36
2024
Q3
$1.32M Buy
1,494
+200
+15% +$180K 0.49% 34
2024
Q2
$1.17M Buy
1,294
+5
+0.4% +$4K 0.56% 33
2024
Q1
$1M Hold
1,289
0.5% 32
2023
Q4
$751K Buy
+1,289
New +$752K 0.42% 34

Other funds holding LLY

Sterling Wealth Management's LLY Position: Q1 2026 in Review

Sterling Wealth Management increased its Eli Lilly (LLY) stake by 0.17% in Q1 2026, buying an estimated $1.01K and bringing the position to 588 shares worth $541K. The position accounts for 0.15% of the portfolio, ranked #56.

Sterling Wealth Management first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.32M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sterling Wealth Management held 588 shares of Eli Lilly worth $541K as of Q1 2026.
  • Sterling Wealth Management bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.15% of Sterling Wealth Management's portfolio in Q1 2026, its #56 holding.
  • Sterling Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • Sterling Wealth Management's Eli Lilly position peaked at $1.32M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sterling Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.